UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-23319
OFI Carlyle Private Credit Fund
(Exact name of registrant as specified in charter)
6803 South Tucson Way, Centennial, Colorado 80112-3924
(Address of principal executive offices) (Zip code)
Joseph Benedetti, Esq.
OC Private Capital, LLC
225 Liberty Street, New York, New York 10281-1008
(Name and address of agent for service)
Registrants telephone number, including area code: (303) 768-3200
Date of fiscal year end: December 31
Date of reporting period: 6/30/2018
Item 1. | Reports to Stockholders. |
Investments | Interest Rate | Maturity Date |
Par/ Principal Amount |
Fair Value |
Corporate Loans (84.4%) | ||||
First Lien Debt (64.2%) | ||||
Air Freight & Logistics (2.5%) | ||||
Trump Card LLC | ||||
Term Loan, Tranche A1 | LIBOR4 + 550, 7.836% | 4/21/2022 | $1,143,682 | $ 1,132,245 |
Revolver 1 | PRIME4 + 450, 9.500% | 4/21/2022 | 17,122 | 16,951 |
Revolver 1 | LIBOR12 + 550, 7.603% | 4/21/2022 | 30,557 | 30,251 |
Revolver 2 | 0.500% | 4/21/2022 | 47,628 | 47,152 |
1,226,599 | ||||
Commerical Services and Supplies (4.0%) | ||||
Constellis Holdings LLC, Term Loan, Tranche B11,3,4 | LIBOR4 + 500, 7.334% | 4/21/2024 | 2,000,000 | 2,010,830 |
Electric Utilities (9.9%) | ||||
Moxie Patriot LLC, Term Loan, Tranche B11 | LIBOR4 + 575, 8.084% | 12/19/2020 | 4,987,310 | 4,946,788 |
Health Care Equipment & Supplies (14.0%) | ||||
Analogic Corp. | ||||
Term Loan, Unitranche1 | LIBOR12 + 600, 8.084% | 6/22/2024 | 6,495,756 | 6,366,653 |
Revolver 2 | 0.500% | 6/22/2023 | 618,644 | 606,348 |
6,973,001 | ||||
Information Technology Services (15.9%) | ||||
IQOR US, Inc., Term Loan, Tranche B1,3,4 | LIBOR4 + 500, 7.337% | 4/1/2021 | 5,000,000 | 5,001,250 |
Sungard Availability Services Capital, Inc. | ||||
Term Loan, Tranche B1 | LIBOR12 + 1000, 11.976% | 10/1/2022 | 2,938,487 | 2,904,385 |
Term Loan, Tranche B1 | PRIME4 + 900, 14.000% | 10/1/2022 | 1,421 | 1,405 |
7,907,040 | ||||
Internet Software & Services (2.4%) | ||||
Internap Corp., Term Loan1,3,4 | LIBOR12 + 575, 7.830% | 4/6/2022 | 1,188,832 | 1,199,234 |
Professional Services (3.5%) | ||||
NES Global Talent Finance US LLC, Term Loan, Tranche B1 | LIBOR4 + 550, 7.856% | 5/11/2023 | 1,750,000 | 1,750,000 |
Software (12.0%) | ||||
DTI Holdco, Inc., Term Loan, Tranche B1,3,4 | LIBOR12 + 475, 6.827% | 10/2/2023 | 5,000,000 | 5,003,150 |
Exela Intermediate LLC, Term Loan, Tranche B1,3,4 | LIBOR4 + 650, 8.826% | 7/12/2023 | 1,000,000 | 1,003,250 |
6,006,400 | ||||
Total First Lien Debt (Cost $32,090,546) | 32,019,892 |
Investments | Interest Rate | Maturity
Date |
Par/
Principal Amount |
Fair
Value |
Second Lien Debt (20.2%) | ||||
Insurance (6.1%) | ||||
Asurion LLC, Term Loan, Tranche B21,3,4 | LIBOR4 + 650, 8.577% | 8/4/2025 | $3,000,000 | $3,048,750 |
Machinery (4.0%) | ||||
NN, Inc., Term Loan1,3,4 | LIBOR12 + 800, 10.097% | 4/14/2023 | 2,000,000 | 1,990,000 |
Road & Rail (10.1%) | ||||
Gruden Acquisition, Inc., Term Loan1,3,4 | LIBOR4 + 850, 10.834% | 8/18/2023 | 5,000,000 | 5,029,175 |
Total Second Lien Debt (Cost $9,987,500) | 10,067,925 | |||
Total Corporate Loans (Cost $42,078,046) | 42,087,817 | |||
Collateralized Loan Obligations (13.3%) | ||||
Barings CLO Ltd., Series 2017-1A, Class F1,5 | LIBOR4 + 745, 9.805% | 7/18/2029 | 2,500,000 | 2,394,005 |
Dryden 41 Senior Loan Fund, Series 2015-41A, Class ER1,5,6 | LIBOR4 + 530, 7.648% | 4/15/2031 | 1,265,000 | 1,240,054 |
Long Point Park CLO Ltd. 1,6,7 | LIBOR4 + 560, 7.588% | 1/17/2030 | 3,000,000 | 3,003,549 |
Total Collateralized Loan Obligations (Cost $6,728,347) | 6,637,608 |
Shares | ||||
Common Stock (0.1%) | ||||
Health Care Equipment & Supplies (0.1%) | ||||
ANLG Holdings, LLC 3 (Cost $64,683) | 64,683 | $ 64,683 | ||
Total Investments, at Value (Cost $48,871,076) | 97.8% | 48,790,108 | ||
Net Other Assets (Liabilities) | 2.2% | 1,109,031 | ||
Net Assets | 100.0% | $49,899,139 |
Footnotes to Consolidated Statement of Investments |
1. Represents the interest rate for a variable or increasing rate security, determined as [Reference Rate + Basis-point spread]. Stated interest rate represents the "all-in" rate as of June 30, 2018. |
2. Security is an unfunded loan commitment. See Note 9 of the accompanying Consolidated Notes. |
3. Non-income producing security. |
4. All or a portion of the security position will settle, after period end, in the ordinary course on a settlement date beyond the period expected by loan market participants and is subject to delayed compensation. The rate shown is the contractual interest rate. See Note 4 of the accompanying Consolidated Notes. |
5. Represents securities sold under Rule 144A, which are exempt from registration under the Securities Act of 1933, as amended. These securities amount to $3,634,059 or 7.3% of the Fund's net assets at period end. |
6. All or a portion of this security is owned by the Subsidiary (as defined herein). See Note 2 of the accompanying Consolidated Notes. |
7. Security exempt from registration under Regulation S of the Securities Act of 1933, which exempts from registration securities offered and sold outside the United States. Security may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act of 1933. The acquisition date of such security was June 8, 2018 with a cost of $3,026,250. The total fair value of this security is $3,003,549 or 6.0% of the Fund's net assets. |
Definitions | |
LIBOR12 | London Interbank Offered Rate-Monthly |
LIBOR4 | London Interbank Offered Rate-Quarterly |
PRIME4 | United States Prime Rate-Quarterly |
Assets | |
Investments, at value (cost $48,871,076)—see accompanying consolidated statement of investments | $ 48,790,108 |
Cash | 25,275,541 |
Cash collateral for borrowings | 20,000,000 |
Receivables and other assets: | |
Adviser reimbursement | 434,778 |
Deferred offering costs | 340,134 |
Interest | 221,410 |
Investments sold | 12,690 |
Other | 102,823 |
Total assets | 95,177,484 |
Liabilities | |
Payables and other liabilities: | |
Investments purchased | 24,906,370 |
Payable for borrowings | 20,000,000 |
Accrued organizational costs | 122,266 |
Accrued offering costs | 67,161 |
Management fees | 53,425 |
Distribution and shareholder service plan fees | 30,251 |
Trustees' compensation and expenses | 14,012 |
Transfer agent fees | 9,688 |
Interest expense and fees on borrowings | 6,312 |
Shareholder communications | 4,844 |
Other | 64,016 |
Total liabilities | 45,278,345 |
Net Assets | $ 49,899,139 |
Composition of Net Assets | |
Par value of shares of beneficial interest | 5,000 |
Additional paid-in capital | 49,995,000 |
Accumulated net investment loss | (20,061) |
Accumulated net realized gain on investments | 168 |
Net unrealized depreciation on investments | (80,968) |
Net Assets | $ 49,899,139 |
Net Asset Value Per Share | |
Net asset value and redemption price per share (based on net assets of $49,899,139 and 5,000,000 shares of beneficial interest outstanding) | $ 9.98 |
Maximum offering price per share (net asset value plus sales charge of 3.50% of offering price) | $ 10.34 |
Investment Income | |
Interest | $ 87,591 |
Expenses | |
Management fees | 53,425 |
Distribution and shareholder service plan fees | 30,251 |
Transfer agent fees | 9,688 |
Shareholder communications fees | 4,844 |
Interest expense and fees on borrowings | 6,312 |
Legal, auditing and other professional fees | 146,296 |
Custodian fees and expenses | 16,740 |
Trustees' compensation and expenses | 14,012 |
Other expenses | 18,215 |
Total expenses | 299,783 |
Less waivers and reimbursements of expenses | (192,131) |
Net expenses | 107,652 |
Net Investment Loss | (20,061) |
Realized and Unrealized Gain (Loss) | |
Net realized gain on investment transactions | 168 |
Net change in unrealized appreciation/depreciation in investment transactions | (80,968) |
Net Decrease in Net Assets Resulting from Operations | $ (100,861) |
1. For the period from June 4, 2018 (commencement of operations) to June 30, 2018. |
Period Ended June 30, 20181 (Unaudited) | |
Operations | |
Net investment loss | $ (20,061) |
Net realized gain | 168 |
Net change in unrealized appreciation/depreciation | (80,968) |
Net decrease in net assets resulting from operations | (100,861) |
Beneficial Interest Transactions | |
Net increase in Beneficial Interest Transactions | 49,900,000 |
Net Assets | |
Total increase | 49,799,139 |
Beginning of period | 100,000 2 |
End of period (including accumulated net investment loss of $20,061) | $ 49,899,139 |
1. For the period from June 4, 2018 (commencement of operations) to June 30, 2018. |
2. Reflects the value of OppenheimerFunds, Inc.'s seed capital invested on May 7, 2018. |
Cash Flows from Operating Activities | |
Net decrease in net assets from operations | $ (100,861) |
Adjustments to reconcile net decrease in net assets from operations to net cash used in operating activities: | |
Purchase of investment securities | (48,903,527) |
Proceeds from disposition of investment securities | 33,033 |
Premium amortization | 192 |
Discount accretion | (606) |
Net realized gain on investment transactions | (168) |
Net change in unrealized appreciation/depreciation on investment transactions | 80,968 |
Change in assets: | |
Decrease in other assets | 147,607 |
Increase in interest receivable | (221,410) |
Increase in receivable for securities sold | (12,690) |
Increase in adviser reimbursement | (434,778) |
Decrease in deferred offering costs | 26,087 |
Change in liabilities: | |
Decrease in other liabilities | (116,512) |
Increase in payable for securities purchased | 24,906,370 |
Decrease in accrued organizational costs | (128,164) |
Net cash used in operating activities | (24,724,459) |
Cash Flows from Financing Activities | |
Proceeds from borrowings | 20,000,000 |
Increase in cash collateral for borrowings | (20,000,000) |
Proceeds from shares sold | 49,900,000 |
Net cash provided by financing activities | 49,900,000 |
Net increase in cash | 25,175,541 |
Cash, beginning balance | 100,000 |
Cash, ending balance | $ 25,275,541 |
1. For the period from June 4, 2018 (commencement of operations) to June 30, 2018. |
Period Ended June 30, 20181 (Unaudited) | |
Per Share Operating Data | |
Net asset value, beginning of period | $10.00 |
Income (loss) from investment operations: | |
Net investment loss2 | (0.00) 3 |
Net realized and unrealized loss | (0.02) |
Total from investment operations | (0.02) |
Net asset value, end of period | $9.98 |
Total Return, at Net Asset Value | (0.20)% |
Ratios/Supplemental Data | |
Net assets, end of period (in thousands) | $49,899 |
Average net assets (in thousands) | $49,950 |
Ratios to average net assets:4 | |
Net investment loss | (0.56)% |
Expenses, before waivers and reimbursements of expenses, excluding specific expenses listed below | 7.40% |
Interest and fees from borrowings | 0.18% |
Distribution and shareholder service plan fees | 0.85% |
Total expenses | 8.43% |
Expenses after waivers and reimbursements of expenses5 | 3.03% |
Portfolio turnover rate | 0% 6 |
1. For the period from June 4, 2018 (commencement of operations) to June 30, 2018. |
2. Per share amounts calculated based on the average shares outstanding during the period. |
3. Less than $0.005 per share. |
4. Annualized for periods less than one full year. |
5. Expenses after waivers and reimbursements of expenses, excluding interest and fees from borrowings and distribution and shareholder service fees, was 2.00% of net assets on an annualized basis. |
6. Less than 0.005%. |
Total market value of investments | $4,243,603 |
Net assets | $ (41,262) |
Net income (loss) | $ (6,312) |
Net realized gain (loss) | $ 0 |
Net change in unrealized appreciation/depreciation | $(34,950) |
Federal tax cost of securities | $48,871,076 |
Gross unrealized appreciation | 88,675 |
Gross unrealized depreciation | (169,643) |
Net unrealized depreciation | $ (80,968) |
Level
1— Unadjusted Quoted Prices |
Level
2— Other Significant Observable Inputs |
Level
3— Significant Unobservable Inputs |
Value | |
Assets
Table Investments, at Value: |
||||
Corporate Loans | $ — | $ 42,087,817 | $ — | $ 42,087,817 |
Collateralized Loan Obligations | — | 6,637,608 | — | 6,637,608 |
Common Stock | — | 64,683 | — | 64,683 |
Total Assets | $— | $48,790,108 | $— | $48,790,108 |
Period Ended June 30, 20181,2 | ||
Shares | Amount | |
Sold | 4,990,000 | $49,900,000 |
Net increase | 4,990,000 | $49,900,000 |
1. For the period from June 4, 2018 (commencement of operations) to June 30, 2018. |
2. The Fund sold 10,000 shares of the Fund at a value of $100,000 to OFI upon seeding of the Fund on May 7, 2018. These amounts are not reflected in the table above. |
Purchases | Sales | |
Investment securities | $48,903,527 | $33,033 |
Average Outstanding Loan Balance Under the Facility | $20,000,000 |
Average Interest Rate of Outstanding Loan Balance (including the effect of commitment fees) | 3.7875% |
Trustees | Mark Garbin, Trustee Sanjeev Handa, Trustee Joan McCabe, Trustee Kamal Bhatia, Trustee |
Adviser | OC Private Capital, LLC |
Sub-Adviser | Carlyle Global Credit Investment Management L.L.C. |
Distributor | OppenheimerFunds Distributor, Inc. |
Transfer
and Shareholder Servicing Agent |
OFI Global Asset Management, Inc. |
Sub-Transfer Agent | DST Systems, Inc. |
Independent
Registered Public Accounting Firm |
Ernst & Young LLP |
Legal Counsel | Dechert LLP |
Item 2. | Code of Ethics. |
Not applicable to semiannual reports.
Item 3. | Audit Committee Financial Expert. |
Not applicable to semiannual reports.
Item 4. | Principal Accountant Fees and Services. |
Not applicable to semiannual reports.
Item 5. | Audit Committee of Listed Registrants |
Not applicable to semiannual reports.
Item 6. | Schedule of Investments. |
(a) | The complete schedule of investments is included in Item 1 of this Form N-CSR. |
(b) | Not applicable. |
Item 7. | Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies. |
Not applicable to semiannual reports.
Item 8. | Portfolio Managers of Closed-End Management Investment Companies. |
(a)(1) Not applicable to semiannual reports.
(a)(2) Not applicable to semiannual reports.
(a)(3) Not applicable to semiannual reports.
(a)(4) Not applicable to semiannual reports.
(b) No changes have been made to the portfolio managers identified in the most recently filed registration statement on Form N-2 (File Nos. 333-222106 and 811-23319) for OFI Carlyle Private Credit Fund.
Item 9. | Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers. |
Not applicable.
Item 10. | Submission of Matters to a Vote of Security Holders. |
For the period covered by this Form N-CSR filing, there have been no material changes to the procedures by which shareholders may recommend nominees to the registrants Board of Trustees.
Item 11. | Controls and Procedures. |
(a) | Based on their evaluation of the registrants disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940 (17 CFR 270.30a-3(c)) as of 6/30/2018, the registrants principal executive officer and principal financial officer found the registrants disclosure controls and procedures to provide reasonable assurances that information required to be disclosed by the registrant in the reports that it files under the Securities Exchange Act of 1934 (a) is accumulated and communicated to registrants management, including its principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure, and (b) is recorded, processed, summarized and reported, within the time periods specified in the rules and forms adopted by the U.S. Securities and Exchange Commission. |
(b) | There have been no changes in the registrants internal controls over financial reporting that occurred during the registrants second fiscal quarter of the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrants internal control over financial reporting. |
Item 12. | Disclosure of Securities Lending Activities for Closed-End Management Investment Companies. |
(a) | Not applicable. |
(b) | Not applicable. |
Item 13. | Exhibits. |
(a)(1) | Not applicable to semiannual reports. |
(a)(2) | Exhibits attached hereto. |
(a)(3) Not applicable.
(a)(4) Not applicable.
(b) | Exhibits attached hereto. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
OFI Carlyle Private Credit Fund | ||
By: | /s/ Kamal Bhatia | |
Kamal Bhatia | ||
Principal Executive Officer | ||
Date: | 8/28/2018 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/ Kamal Bhatia | |
Kamal Bhatia | ||
Principal Executive Officer | ||
Date: | 8/28/2018 | |
By: | /s/ Julie Burley | |
Julie Burley | ||
Principal Financial Officer | ||
Date: | 8/28/2018 |